These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 35726096)

  • 21. Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview.
    Brandão PRP; Munhoz RP; Grippe TC; Cardoso FEC; de Almeida E Castro BM; Titze-de-Almeida R; Tomaz C; Tavares MCH
    J Neurol Sci; 2020 Dec; 419():117177. PubMed ID: 33068906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
    Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
    Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies.
    Szeto JYY; Halliday GM; Naismith SL; Lewis SJG
    J Geriatr Psychiatry Neurol; 2017 Jul; 30(4):196-205. PubMed ID: 28639878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Impairment and Dementia in Parkinson Disease.
    Goldman JG; Sieg E
    Clin Geriatr Med; 2020 May; 36(2):365-377. PubMed ID: 32222308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
    Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
    J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease.
    Behnke S; Pilotto A; Liepelt-Scarfone I; Yilmaz R; Pausch C; Dieterich S; Bürmann J; Spiegel J; Dillmann U; Unger M; Posner I; Berg D
    Parkinsonism Relat Disord; 2019 Sep; 66():68-73. PubMed ID: 31324557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
    Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
    Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy.
    Ruiz Barrio I; Miki Y; Jaunmuktane ZT; Warner T; De Pablo-Fernandez E
    Neurology; 2023 Mar; 100(10):e998-e1008. PubMed ID: 36526431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment.
    Knox MG; Adler CH; Shill HA; Driver-Dunckley E; Mehta SA; Belden C; Zamrini E; Serrano G; Sabbagh MN; Caviness JN; Sue LI; Davis KJ; Dugger BN; Beach TG
    Mov Disord; 2020 May; 35(5):845-850. PubMed ID: 32034933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
    Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
    Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodegeneration across stages of cognitive decline in Parkinson disease.
    Weintraub D; Doshi J; Koka D; Davatzikos C; Siderowf AD; Duda JE; Wolk DA; Moberg PJ; Xie SX; Clark CM
    Arch Neurol; 2011 Dec; 68(12):1562-8. PubMed ID: 22159053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.